Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.46 |
| ▸ | ALDH1A3 | P47895 | 11/20 | 0.46 |
| ▸ | ALDH1A2 | O94788 | 10/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3612236 | 0.79 | RAB9A (0.61) | MEN1KMT2ARAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL3612259 | 0.78 | FSCN1 (0.54) | RAB9AALDH1A1SMN1; SMN2HPGDKDM4E | |
| SCHEMBL3612174 | 0.77 | RAB9A (0.59) | MEN1KMT2ARAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL3608848 | 0.77 | RAB9A (0.55) | MEN1KMT2ARAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL3615612 | 0.76 | LMNA (0.60) | MEN1KMT2ARAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL3602075 | 0.76 | POLB (0.62) | MEN1KMT2ARAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL3614046 | 0.76 | LMNA (0.55) | MEN1KMT2ARAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL31473303 | 0.75 | MEN1 (0.53) | MEN1KMT2ARAB9AALDH1A1ALDH1A3 | |
| SCHEMBL3597543 | 0.75 | SMN1; SMN2 (0.52) | MEN1KMT2ARAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL3616124 | 0.75 | SMN1; SMN2 (0.65) | MEN1KMT2ARAB9AALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260007745-A1 | ALDH Inhibitors to Promote Immune Cell Expansion | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) | 2026-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007745-A1 | ALDH Inhibitors to Promote Immune Cell Expansion | ALDH1A1, ALDH3A1, ALDH2 | MEN1 3847/4885KMT2A 1245/4885RAB9A 1888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.